Altech® Exhalation Valve (Single Limb and Dual Limb)
Device Facts
| Record ID | K210992 |
|---|---|
| Device Name | Altech® Exhalation Valve (Single Limb and Dual Limb) |
| Applicant | Meditera Tibbi Malzeme San VE Tic AS |
| Product Code | CBP · Anesthesiology |
| Decision Date | Dec 23, 2021 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 868.5870 |
| Device Class | Class 2 |
| Attributes | Therapeutic, Pediatric |
Indications for Use
The exhalation valves are intended to be used in ventilator circuits consistent with the indicated use of the ventilator to which they are attached. The single limb model directs flow and allows for pressure monitoring and may be used within hospitals and for home care use. The dual limb model regulates flow and is for use in hospitals and for home care use. The exhalation valve are used with adults, pediatrics, and neonates. The exhalation valves are for single patient use and can be used for a maximum of 30 days
Device Story
Altech® Exhalation Valves (Single and Dual Limb) function as components of ventilator circuits; they regulate gas flow and pressure. Operation relies on a control line (L port) receiving pressure from the ventilator; pressurization closes the valve during inspiration to deliver positive pressure to the patient; pressure release opens the valve during exhalation to vent gases. Single limb models exhaust expired gas through a bottom opening; dual limb models exhaust through the valve end. Used in hospitals and home care; operated by healthcare professionals or patients/caregivers per ventilator instructions. Single-patient use; maximum 30-day duration. Output is the regulation of circuit pressure and gas flow, enabling effective mechanical ventilation.
Clinical Evidence
Bench testing only. Performance evaluated via ISO 5356-1 (fittings), ISO 5367 (leakage <70 ml/min, resistance to flow), and ISO 18562 (particulates/VOCs). Biocompatibility confirmed via ISO 10993-5 (cytotoxicity), ISO 10993-10 (sensitization/irritation), and ISO 10993-11 (pyrogenicity/toxicity). Testing performed pre- and post-aging and after 30 days of simulated use.
Technological Characteristics
Non-rebreathing valve; 15/22 mm conical fittings (ISO 5356-1). Operates via pneumatic pressure from ventilator. Single and dual limb configurations. Non-sterile, single-patient use, 30-day lifespan. Materials evaluated per ISO 10993 and ISO 18562 standards.
Indications for Use
Indicated for use in ventilator circuits for adult, pediatric, and neonatal patients requiring mechanical ventilation in hospital and home care settings.
Regulatory Classification
Identification
A nonrebreathing valve is a one-way valve that directs breathing gas flow to the patient and vents exhaled gases into the atmosphere.
Predicate Devices
- Intersurgical Exhalation valve (K132143)
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services seal on the left and the FDA acronym along with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name written out to the right of it.
December 23, 2021
Meditera Tibbi Malzeme San Ve TIC AS % Paul Dryden Consultant Meditera Tibbi Malzeme San Ve TIC AS c/o ProMedic LLC 131 Bay Point Dr NE St. Petersburg, Florida 33704
Re: K210992
Trade/Device Name: Exhalation Valve (Single Limb, Dual Limb) Regulation Number: 21 CFR 868.5870 Regulation Name: Nonrebreathing Valve Regulatory Class: Class II Product Code: CBP Dated: November 22, 2021 Received: November 24, 2021
Dear Paul Dryden:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Brandon Blakely Assistant Director DHT1C: Division of Sleep Disordered Breathing, Respiratory and Anesthesia Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
510(k) Number (if known) K210992
Device Name
Altech® Exhalation Valve (Single Limb and Dual Limb)
Indications for Use (Describe)
The exhalation valves are intended to be used in ventilator circuits consistent with the indicated use of the ventilator to which they are attached.
The single limb model directs flow and allows for pressure monitoring and may be used within hospitals and for home care use.
The dual limb model regulates flow and is for use in hospitals and for home care use.
The exhalation valve are used with adults, pediatrics, and neonates.
The exhalation valves are for single patient use and can be used for a maximum of 30 days
Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
## 510(k) Summarv Page 1 of 6
| Date Prepared: | 22-Dec-21 |
|----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|
| Sponsor: | Meditera Tıbbi Malzeme San. ve Tic. A.Ş.<br>İbni Melek OSB Mah. TOSBİ Yol 4 Sok<br>No: 29 Tire Organize Sanayi Bölgesi<br>Tire / İzmir / Turkey |
| | Cenk Kılıç Kalkan, Quality Manager<br>T: +90 232 513 51 10 |
| Submission Correspondent: | Paul Dryden<br>ProMedic, LLC<br>131 Bay Point Dr NE<br>St. Petersburg, FL 33704 |
| Proprietary or Trade Name: | Altech® Exhalation Valves (Single Limb and Dual Limb) |
| Regulation Number: | 21 CFR 868.5870 |
| Regulation Name: | Non-rebreathing Valve |
| Product code: | CBP |
| Predicate Device: | Exhalation valve - K132143 |
| Manufacturer: | Intersurgical |
| Regulation Number: | 21 CFR 868.5870 |
| Regulation Name: | Non-rebreathing Valve |
| Product code: | CBP |
#### Device Description:
The Altech® Exhalation Valves (Single Limb) are available in 2 configurations intended for use in Single and Dual Limb ventilator circuits. The difference between the configurations is location of exhaust of the expired gas to the room. In the Single limb, the valve is integrated to the limb and expired gas exhausts through the opening below the valve whereas in the valve is attached to the end of the exhalation limb and the expired gas exhausts through device end of the valve.
#### Principle of Operation:
Exhalation Valves have control line (L port) which passes the pressure from the ventilator to open or close the internal valve.
When starting to deliver an inspiratory breath, the ventilator pressurizes the exhalation valve, closing the exhalation path so that the positive pressure is delivered to the patient. At the end of inspiration, the pressure releases, the Exhalation valve gas pathway opens and the patient's exhaled gases then are vented to the room through the exhalation limb from device end of the valve for dual limb circuits or exhausted through the bottom opening of the valve for the single limb circuit.
#### Indications for Use:
The exhalation valves are intended to be used in ventilator circuits consistent with the indicated use of the ventilator to which they are attached.
The single limb model directs flow and allows for pressure monitoring and may be used within hospitals
{4}------------------------------------------------
### 510(k) Summarv Page 2 of 6
and for home care use.
The dual limb model regulates flow and is for use in hospitals and for home care use.
The exhalation valve are used with adults, pediatrics, and neonates.
The exhalation valves are for single patient use and can be used for a maximum of 30 days
#### Patient Population:
Adult, Pediatric and Neonates on mechanical ventilation.
#### Environments of use:
They may be used with ventilators that are indicated for home settings. In all cases the Exhalation valves are part of the ventilator circuit and would be consistent with the indications of the ventilator to which they are attached.
#### Difference Between Subject and Predicate
Table 2 below presents the differences between the subject device and the predicate which are:
- Indications for use include the addition of neonate population and adding a Dual limb model in ● addition to the single limb model
- . The technological characteristics are similar between the subject device and the predicate in that they both use a valve which opened or closed by pressure that is applied by the ventilator. The only difference is that the predicate does not offer a dual limb design which connects to a dual limb circuit thus directing expired gases to the ventilator whereas the single limb design for both devices exhausts the expired gases to the room as they connect to a single limb circuit.
- . Performance and Specifications are similar and the differences in expiratory resistance and leakage are within acceptable ranges
- Patient population of adding Neonates
- The use of the subject device is dependent upon the ventilator to which it is attached and its O indications for use.
#### Non-clinical Performance Data
Non-clinical performance testing is summarized in the below table.
| Test Methodology | Purpose | Results |
|------------------|-------------------------------------------|------------------------------------------|
| ISO 5356-1 | Conical fittings for 15 / 22 mm | Fittings were tested according to ISO |
| | Testing was performed pre- and post-aging | 5356-1 and meet the performance criteria |
| | and after 30 days use and after storage | |
| | conditions | |
| ISO 5367 | Leakage | Leakage of <70 ml/min |
| | Testing was performed pre- and post-aging | |
| | and after 30 days use and after storage | |
| | conditions | |
| | Resistance to Flow | Adult <0.06 cmH2O/l/m |
Table 1 - Summary of Non-clinical Testing
{5}------------------------------------------------
## 510(k) Summary Page 3 of 6
| Storage condition and<br>testing post-aging | Testing was performed pre- and post-aging<br>and after 30 days use | Pediatrics $< 0.12$ cmH2O/l/m | | |
|-----------------------------------------------|--------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|---------------------|
| | Evaluate performance after exposure to<br>various storage conditions and post-aging | Neonate $< 0.74$ cmH2O/l/m | | |
| Performance after 30 days | Evaluate performance after 30 days<br>continuous use | Testing of leakage, resistance to flow met<br>the acceptance criteria per each standard | | |
| Performance under<br>various ventilator modes | To evaluate performance when used in<br>various ventilator modes | Testing over different ventilator modes<br>was performed to confirm the<br>compatibility of the device with a<br>ventilator | | |
| | | ISO 10993-5 | Evaluate materials for cytotoxicity | Found non-cytotoxic |
| | | ISO 10993-10 | Evaluate materials for sensitization and<br>irritation | Non-sensitizer |
| Non-irritant | | | | |
| ISO 10993-11 | Evaluate materials for Material Mediated<br>Pyrogenicity and Acuta Systemic Toxicity | Non-pyrogenic | | |
| | | Non-toxic | | |
| ISO 18562-2 | Particulate Material | Met the predefined acceptance criteria | | |
| ISO 18562-3 | Evaluate Volatile Organic Chemicals | Toxicological Risk Assessment resulted<br>in Margin of Safety >1 | | |
The testing demonstrated the performance of the subject device to the above listed standards.
Comparative testing to the predicate as discussed in Table 2 below demonstrate the 2 devices to be substantially equivalent in performance, technological characteristics, principles of operation and indications for use.
# Substantial Equivalence Conclusion
The conclusions drawn from the nonclinical tests demonstrate that the Altech® Exhalation Valve (Single Limb and Dual Limb) demonstrate substantially equivalent to the predicate.
{6}------------------------------------------------
# 510(k) Summary Page 4 of 6
# Table 2 - Comparison - Subject vs. Predicate
| | Subject Device<br>Altech® Exhalation Valves | Predicate Device (K132143)<br>Intersurgical Exhalation valve | Comparison | |
|--------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | (Single Limb and Dual Limb) Models | | | |
| Classification | Product Code - CBP | Product Code - CBP | Similar | |
| | CFR 868.5870 | CFR 868.5870 | | |
| | Classification – Non-rebreathing Valve | Classification – Non-rebreathing Valve | | |
| Indications for Use | The exhalation valves are intended to be used in ventilator<br>circuits consistent with the indicated use of the ventilator<br>to which they are attached.<br>The single limb model directs flow and allows for pressure<br>monitoring and may be used within hospitals and for home<br>care use.<br>The dual limb model regulates flow and is for use in<br>hospitals and for home care use.<br>The exhalation valve are used with adults, pediatrics, and<br>neonates.<br>The exhalation valves are for single patient use and can be<br>used for a maximum of 30 days. | The exhalation valves are used to control<br>Inspiratory pressure and expel the expired air from<br>a patient being ventilated via a single limb<br>breathing system. The exhalation valve and single<br>limb breathing systems are used with<br>adults/pediatrics and prescribed by a Physician. A<br>pediatric population is defined as 10 kg to 40 kg in<br>weight. The product is not for use in neonates.<br>The device can be used within hospitals and for<br>home care use. It is a single patient use device and<br>can be used for a maximum of 30 days. | The subject has models for use in<br>both single and dual limb circuits.<br>Added neonates. Otherwise they are<br>similar. | |
| Patient pollution | Adult / Pediatric / Neonates | Adult / Pediatric | Similar except the subject can be<br>used with neonates if the ventilator to<br>which it is attached is so intended | |
| Environment of Use | Hospital and home consistent with the ventilator to which<br>they are attached | Hospital and home | Similar | |
| Fundamental<br>scientific technology | Place in-line with ventilator circuit, pressurized by<br>ventilator to open / close to direct flow | Place in-line with ventilator circuit, pressurized by<br>ventilator to open / close to direct flow | Similar | |
| Disposable | Single patient, disposable up to 30 day use | Single patient, disposable up to 30 day use | Similar | |
| Non-sterile | Yes | Yes | Similar | |
| | | Subject Device<br>Altech® Exhalation Valves<br>(Single Limb and Dual Limb) Models | Predicate Device (K132143)<br>Intersurgical Exhalation valve | Comparison |
| Design Performance | | | | |
| Resistance to Flow<br>(cmH2O) | Dual<br>Inspiration<br>(placed on the expiration<br>side only) | Single<br>Inspiration<br>@ 30 Lpm – 0<br>@ 15 Lpm – 0<br>@ 2.5 Lpm – 0<br>Expiration<br>@ 30 Lpm – 1.95<br>@ 15 Lpm – 1.36<br>@ 2.5 Lpm – 0.80 | @ 30 Lpm – 0.9<br>@ 10 Lpm – 0.6 | Similar<br>Subject device included testing for<br>neonate. The predicate as a Single<br>limb there is no difference between<br>inspiratory and expiratory limbs.<br>The Dual limb configuration is<br>placed on the exhalation side of the<br>circuit. |
| Leakage in main<br>body ml/min | 6 | 2 | <0.5 | The difference in leakage is<br>compensated by the ventilator and<br>does not raise new risk concerns |
| Pressure Ratio | | 1:3 | 1:1.5 and 1:2 | Similar |
| As Patient connection<br>ISO 5356 | | 22 mm / 22/15 mm | 22 mm / 22/15 mm | Similar |
| Shelf-life | | 3 years | 5 years | Similar |
| Storage testing | -20°C to +50°C | | -20°C to +50°C | Similar |
| Inspiratory Trigger | 1 to 9 for pressure and volume control setting | | < 30 ms | Similar |
| Expiratory trigger | 1 to 9 Pressure | | Not specified | Similar |
| | Subject Device | Predicate Device (K132143) | Comparison | |
| | Meditera Tibbi Exhalation Valve | Intersurgical Exhalation valve | | |
| | Dual / Single Limb Models | | | |
| Biocompatibility | ISO 10993-5 - Cytotoxicity | ISO 10993 details not listed | Similar<br>All applicable tests were performed<br>for the type of patient contact | |
| | ISO 10993-10 - Sensitization and Irritation | | | |
| | ISO 10993-11 - Material Mediated Pyrogenicity | | | |
| | ISO 18562-2 - Particulate Material | | | |
| | ISO 18562-3 – Volatile Organic Chemicals | | | |
| | Toxicology Risk Assessment | | | |
| | Biological Evaluation | | | |
{7}------------------------------------------------
# 510(k) Summary Page 5 of 6
{8}------------------------------------------------
# 510(k) Summary Page 6 of 6
